Updated Jul 16, 2026
Rao Raghu is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Raghu Rao is a corporate executive known for his roles at Sonnet BioTherapeutics Holdings, Inc., where he has served as Director and Interim CEO. His involvement in SEC filings indicates active participation in corporate governance.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 22.4K | — | |
| 2025-07-11 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 20.0K | — | |
| 2024-12-05 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 373 | — |
Raghu Rao is a corporate executive known for his roles at Sonnet BioTherapeutics Holdings, Inc., where he has served as Director and Interim CEO. His involvement in SEC filings indicates active participation in corporate governance.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Rao Raghu profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.